Generally Accepted Scientific Knowledge in Applications for Drug and Biological Products: Nonclinical Information
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
May 24, 2023
May 27, 2023
80a1d387-00c7-42b3-90ef-982941cdff8b
Related Documents
Use of Bayesian Methodology in Clinical Trials of Drug and Biological Products: Draft Guidance for Industry
Guidance DocumentJanuary 9, 2026Center for Drug Evaluation and Research
Regulatory Considerations for Prescription Drug Use-Related Software
Guidance DocumentSeptember 19, 2023Center for Drug Evaluation and Research
Nonproprietary Naming of Biological Products: Update Guidance for Industry
Guidance DocumentMarch 8, 2019Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox